Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5449]

Anastrazole offers higher breast cancer-free survival rates than tamoxifen...

Prof Richard Margolese - The Jewish General Hospital, McGill University...

Anastrazole offers higher breast cancer-free survival rates than tamoxifen following DCIS ( Prof Richard Margolese - The Jewish General Hospital, McGill University, Montreal, Canada )

Eribulin extends overall survival for patients with advanced liposarcoma and...

Dr Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium

Eribulin extends overall survival for patients with advanced liposarcoma and leiomyosarcoma ( Dr Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium )

Extensive lymph node surgery may not be necessary for some patients with...

Prof Claus Garbe - University of Tübingen, Tübingen, Germany.

Extensive lymph node surgery may not be necessary for some patients with melanoma ( Prof Claus Garbe - University of Tübingen, Tübingen, Germany. )

First effective adjuvant chemotherapy for high-risk, localised prostate cancer

Prof Howard Sandler - Cedars Sinai Medical Center, Los Angeles, USA.

First effective adjuvant chemotherapy for high-risk, localised prostate cancer ( Prof Howard Sandler - Cedars Sinai Medical Center, Los Angeles, USA. )

New ibrutinib combination regimen shows substantial benefits in relapsed...

Prof Asher Chanan-Khan - Mayo Clinic, Jacksonville, USA

New ibrutinib combination regimen shows substantial benefits in relapsed chronic lymphocytic leukaemia ( Prof Asher Chanan-Khan - Mayo Clinic, Jacksonville, USA )

Nivolumab shows highly promising activity in advanced liver cancer in early...

Dr Anthony El-Khoueiry - University of Southern California Norris Comprehensive...

Nivolumab shows highly promising activity in advanced liver cancer in early-stage trial ( Dr Anthony El-Khoueiry - University of Southern California Norris Comprehensive Cancer Center, Los Angeles, USA )

ecancermedicalscience editor's choice for May 2015

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

ecancermedicalscience editor's choice for May 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

Prostate cancer and pharmacokinetics: Expert discussion

Prof Axel S. Merseburger and Prof Romano Danesi

Prostate cancer and pharmacokinetics: Expert discussion ( Prof Axel S. Merseburger and Prof Romano Danesi )

Latest developments in prostate cancer

Prof Peter Mulders, Prof Axel S. Merseburger, Prof Pablo Maroto, Prof Peter...

Latest developments in prostate cancer ( Prof Peter Mulders, Prof Axel S. Merseburger, Prof Pablo Maroto, Prof Peter Iversen )

Developing technical improvements to bladder radiotherapy using online imaging

Dr Robert Huddart - Institute of Cancer Research, London, UK

Developing technical improvements to bladder radiotherapy using online imaging ( Dr Robert Huddart - Institute of Cancer Research, London, UK )

Advances in prostate cancer focal radiation treatments

Prof Barbara Jereczek - European Institute of Oncology, Milan, Italy

Advances in prostate cancer focal radiation treatments ( Prof Barbara Jereczek - European Institute of Oncology, Milan, Italy )

Targeted Intraoperative radiotherapy plus lumpectomy non-inferior to EBRT in...

Prof Jayant Vaidya - University College London, London, UK

Targeted Intraoperative radiotherapy plus lumpectomy non-inferior to EBRT in preventing breast cancer recurrence ( Prof Jayant Vaidya - University College London, London, UK )

More from ecancer